• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (5069891)   Today's Articles (50)
For: Raemaekers J, Kluin-Nelemans H, Teodorovic I, Meerwaldt C, Noordijk E, Thomas J, Glabbeke MV, Henry-Amar M, Carde P. The achievements of the EORTC Lymphoma Group. European Organisation for Research and Treatment of Cancer. Eur J Cancer 2002;38 Suppl 4:S107-13. [PMID: 11858975 DOI: 10.1016/s0959-8049(01)00446-4] [Citation(s) in RCA: 56] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Number Cited by Other Article(s)
1
Ghigna MR, Thomas de Montpreville V. Mediastinal tumours and pseudo-tumours: a comprehensive review with emphasis on multidisciplinary approach. Eur Respir Rev 2021;30:30/162/200309. [PMID: 34615701 PMCID: PMC9488622 DOI: 10.1183/16000617.0309-2020] [Citation(s) in RCA: 17] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/23/2020] [Accepted: 01/08/2021] [Indexed: 12/02/2022]  Open
2
Male and Female Fertility: Prevention and Monitoring Hodgkin' Lymphoma and Diffuse Large B-Cell Lymphoma Adult Survivors. A Systematic Review by the Fondazione Italiana Linfomi. Cancers (Basel) 2021;13:cancers13122881. [PMID: 34207634 PMCID: PMC8228520 DOI: 10.3390/cancers13122881] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/01/2021] [Revised: 06/02/2021] [Accepted: 06/05/2021] [Indexed: 01/08/2023]  Open
3
Using both clinical research and population-based cancer registry in long-term research- a case study using EORTC trials and the Dutch national cancer registry (IKNL). J Cancer Policy 2020. [DOI: 10.1016/j.jcpo.2020.100226] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
4
High burden of subsequent malignant neoplasms and cardiovascular disease in long-term Hodgkin lymphoma survivors. Br J Cancer 2018;118:887-895. [PMID: 29381685 PMCID: PMC5886118 DOI: 10.1038/bjc.2017.476] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/18/2017] [Revised: 12/04/2017] [Accepted: 12/04/2017] [Indexed: 12/11/2022]  Open
5
Radiation Therapy in Hodgkin’s Lymphoma. Radiat Oncol 2017. [DOI: 10.1007/978-3-319-52619-5_19-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]  Open
6
Liu L, Giusti F, Schaapveld M, Aleman B, Lugtenburg P, Meijnders P, Hutchings M, Lemmens V, Bogaerts J, Visser O. Survival differences between patients with Hodgkin lymphoma treated inside and outside clinical trials. A study based on the EORTC-Netherlands Cancer Registry linked data with 20 years of follow-up. Br J Haematol 2016;176:65-75. [DOI: 10.1111/bjh.14379] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2016] [Accepted: 07/20/2016] [Indexed: 01/07/2023]
7
van Nimwegen FA, Cutter DJ, Schaapveld M, Rutten A, Kooijman K, Krol AD, Janus CP, Darby SC, van Leeuwen FE, Aleman BM. Simple Method to Estimate Mean Heart Dose From Hodgkin Lymphoma Radiation Therapy According to Simulation X-Rays. Int J Radiat Oncol Biol Phys 2015;92:153-60. [DOI: 10.1016/j.ijrobp.2015.02.019] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/15/2014] [Revised: 01/23/2015] [Accepted: 02/09/2015] [Indexed: 01/08/2023]
8
van Nimwegen FA, Schaapveld M, Janus CPM, Krol ADG, Raemaekers JMM, Kremer LCM, Stovall M, Aleman BMP, van Leeuwen FE. Risk of diabetes mellitus in long-term survivors of Hodgkin lymphoma. J Clin Oncol 2014;32:3257-63. [PMID: 25154821 DOI: 10.1200/jco.2013.54.4379] [Citation(s) in RCA: 74] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
9
Risk of multiple primary malignancies following treatment of Hodgkin lymphoma. Blood 2014;124:319-27; quiz 466. [DOI: 10.1182/blood-2013-10-532184] [Citation(s) in RCA: 48] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
10
van der Kaaij M, van Echten-Arends J, Heutte N, Meijnders P, Abeilard-Lemoisson E, Spina M, Moser E, Allgeier A, Meulemans B, Lugtenburg P, Aleman B, Noordijk E, Fermé C, Thomas J, Stamatoullas A, Fruchart C, Eghbali H, Brice P, Smit W, Sebban C, Doorduijn J, Roesink J, Gaillard I, Coiffier B, Lybeert M, Casasnovas O, André M, Raemaekers J, Henry-Amar M, Kluin-Nelemans J. Cryopreservation, semen use and the likelihood of fatherhood in male Hodgkin lymphoma survivors: an EORTC-GELA Lymphoma Group cohort study. Hum Reprod 2013;29:525-33. [DOI: 10.1093/humrep/det430] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]  Open
11
Küppers R, Engert A, Hansmann ML. Hodgkin lymphoma. J Clin Invest 2012;122:3439-47. [PMID: 23023715 PMCID: PMC3534167 DOI: 10.1172/jci61245] [Citation(s) in RCA: 214] [Impact Index Per Article: 16.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]  Open
12
van der Kaaij MAE, Heutte N, Meijnders P, Abeilard-Lemoisson E, Spina M, Moser LC, Allgeier A, Meulemans B, Dubois B, Simons AHM, Lugtenburg PJ, Aleman BMP, Noordijk EM, Fermé C, Thomas J, Stamatoullas A, Fruchart C, Brice P, Gaillard I, Doorduijn JK, Sebban C, Smit WGJM, Bologna S, Roesink JM, Ong F, André MPE, Raemaekers JMM, Henry-Amar M, Kluin-Nelemans HC. Parenthood in survivors of Hodgkin lymphoma: an EORTC-GELA general population case-control study. J Clin Oncol 2012;30:3854-63. [PMID: 23008303 DOI: 10.1200/jco.2011.40.8906] [Citation(s) in RCA: 27] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
13
State of the art in the treatment of Hodgkin lymphoma. Nat Rev Clin Oncol 2012;9:450-9. [PMID: 22688578 DOI: 10.1038/nrclinonc.2012.91] [Citation(s) in RCA: 58] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
14
Meijnders P, Carde P, Girinsky T, Kluin-Nelemans J, Henry-Amar M, Raemaekers J, Karrasch M, van der Maazen R. Clinical achievements of the EORTC Lymphoma Group and aspects of future group strategy. EJC Suppl 2012. [DOI: 10.1016/s1359-6349(12)70019-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]  Open
15
Orlacchio A, Schillaci O, Gaspari E, Della Gatta F, Danieli R, Bolacchi F, Ragano Caracciolo C, Mancini A, Simonetti G. Role of [18F]-FDG-PET/MDCT in evaluating early response in patients with Hodgkin's lymphoma. Radiol Med 2012;117:1250-63. [PMID: 22327919 DOI: 10.1007/s11547-012-0792-8] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/07/2011] [Accepted: 06/10/2011] [Indexed: 11/24/2022]
16
van der Kaaij MA, Heutte N, Meijnders P, Abeilard-Lemoisson E, Spina M, Moser EC, Allgeier A, Meulemans B, Simons AH, Lugtenburg PJ, Aleman BM, Noordijk EM, Fermé C, Thomas J, Stamatoullas A, Fruchart C, Brice P, Gaillard I, Bologna S, Ong F, Eghbali H, Doorduijn JK, Morschhauser F, Sebban C, Roesink JM, Bouteloup M, Van Hoof A, Raemaekers JM, Henry-Amar M, Kluin-Nelemans HC. Premature Ovarian Failure and Fertility in Long-Term Survivors of Hodgkin's Lymphoma: A European Organisation for Research and Treatment of Cancer Lymphoma Group and Groupe d'Étude des Lymphomes de l'Adulte Cohort Study. J Clin Oncol 2012;30:291-9. [DOI: 10.1200/jco.2011.37.1989] [Citation(s) in RCA: 74] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
17
ABVD as the Treatment Option in Advanced Hodgkin’s Lymphoma Patients Older than 45 Years. Pathol Oncol Res 2012;18:675-80. [DOI: 10.1007/s12253-011-9494-4] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/03/2011] [Accepted: 09/06/2011] [Indexed: 10/14/2022]
18
Advani RH, Hoppe RT, Maeda LS, Baer DM, Mason J, Rosenberg SA, Horning SJ. Stage I-IIA non-bulky Hodgkin's lymphoma. Is further distinction based on prognostic factors useful? The Stanford experience. Int J Radiat Oncol Biol Phys 2011;81:1374-9. [PMID: 20934280 PMCID: PMC3020265 DOI: 10.1016/j.ijrobp.2010.07.041] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/01/2010] [Revised: 07/13/2010] [Accepted: 07/14/2010] [Indexed: 11/16/2022]
19
Eichenauer DA, Fuchs M, Borchmann P, Engert A. Hodgkin's lymphoma: current treatment strategies and novel approaches. Expert Rev Hematol 2011;1:63-73. [PMID: 21083007 DOI: 10.1586/17474086.1.1.63] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
20
Yamaguchi K, Fujisawa M. Anticancer chemotherapeutic agents and testicular dysfunction. Reprod Med Biol 2011;10:81-87. [PMID: 29699084 DOI: 10.1007/s12522-011-0080-y] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/09/2011] [Accepted: 02/27/2011] [Indexed: 01/15/2023]  Open
21
First-line treatment of Hodgkin's lymphoma. Curr Hematol Malig Rep 2010;1:51-9. [PMID: 20425332 DOI: 10.1007/s11899-006-0018-3] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
22
Hodgkin Lymphoma Across the Age Spectrum: Epidemiology, Therapy, and Late Effects. Semin Radiat Oncol 2010;20:30-44. [DOI: 10.1016/j.semradonc.2009.09.006] [Citation(s) in RCA: 63] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
23
van der Kaaij MAE, Heutte N, van Echten-Arends J, Raemaekers JMM, Carde P, Noordijk EM, Fermé C, Thomas J, Eghbali H, Brice P, Bonmati C, Henry-Amar M, Kluin-Nelemans HC. Sperm quality before treatment in patients with early stage Hodgkin's lymphoma enrolled in EORTC-GELA Lymphoma Group trials. Haematologica 2009;94:1691-7. [PMID: 19850901 DOI: 10.3324/haematol.2009.009696] [Citation(s) in RCA: 47] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]  Open
24
Yung L, Smith P, Hancock BW, Hoskin P, Gilson D, Vernon C, Linch DC. Long Term Outcome in Adolescents with Hodgkin's Lymphoma: Poor Results using Regimens Designed for Adults. Leuk Lymphoma 2009;45:1579-85. [PMID: 15370209 DOI: 10.1080/1042819042000209404] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
25
De Bruin ML, Sparidans J, van't Veer MB, Noordijk EM, Louwman MWJ, Zijlstra JM, van den Berg H, Russell NS, Broeks A, Baaijens MHA, Aleman BMP, van Leeuwen FE. Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes. J Clin Oncol 2009;27:4239-46. [PMID: 19667275 DOI: 10.1200/jco.2008.19.9174] [Citation(s) in RCA: 260] [Impact Index Per Article: 16.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]  Open
26
De Bruin ML, Dorresteijn LDA, van't Veer MB, Krol ADG, van der Pal HJ, Kappelle AC, Boogerd W, Aleman BMP, van Leeuwen FE. Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin lymphoma. J Natl Cancer Inst 2009;101:928-37. [PMID: 19535773 DOI: 10.1093/jnci/djp147] [Citation(s) in RCA: 156] [Impact Index Per Article: 9.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]  Open
27
Diehl V, Behringer K. Could BEACOPP Be the New Standard for the Treatment of Advanced Hodgkin's Lymphoma? Cancer Invest 2009;24:461-5. [PMID: 16777701 DOI: 10.1080/07357900600705789] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
28
Diehl V, Behringer K. Could BEACOPP Be the New Standard for the Treatment of Advanced Hodgkin's Lymphoma (HL)? Cancer Invest 2009;24:713-7. [PMID: 17118782 DOI: 10.1080/07357900600981380] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
29
Favier O, Heutte N, Stamatoullas-Bastard A, Carde P, van't Veer MB, Aleman BMP, Noordijk EM, Thomas J, Fermé C, Henry-Amar M. Survival after Hodgkin lymphoma. Cancer 2009;115:1680-91. [DOI: 10.1002/cncr.24178] [Citation(s) in RCA: 58] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
30
Fuchs M, Eichenauer DA, Nogová L, Diehl V, Engert A. Nodular lymphocyte-predominant Hodgkin lymphoma. Curr Hematol Malig Rep 2008;3:126-31. [PMID: 20425457 DOI: 10.1007/s11899-008-0019-5] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
31
Nogová L, Reineke T, Brillant C, Sieniawski M, Rüdiger T, Josting A, Bredenfeld H, Skripnitchenko R, Müller RP, Müller-Hermelink HK, Diehl V, Engert A. Lymphocyte-predominant and classical Hodgkin's lymphoma: a comprehensive analysis from the German Hodgkin Study Group. J Clin Oncol 2008;26:434-9. [PMID: 18086799 DOI: 10.1200/jco.2007.11.8869] [Citation(s) in RCA: 148] [Impact Index Per Article: 8.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
32
Wood L, Robinson R, Gavine L, Juritz J, Jacobs P. A single unit lymphoma experience: outcome in a Cape Town academic centre. Transfus Apher Sci 2007;37:93-102. [PMID: 17931976 DOI: 10.1016/j.transci.2007.06.002] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/20/2007] [Accepted: 06/22/2007] [Indexed: 11/26/2022]
33
Overview of early response assessment in lymphoma with FDG-PET. Cancer Imaging 2007;7:10-8. [PMID: 17766210 PMCID: PMC1974859 DOI: 10.1102/1470-7330.2007.0004] [Citation(s) in RCA: 66] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 01/23/2007] [Indexed: 01/27/2023]  Open
34
van der Kaaij MAE, Heutte N, Le Stang N, Raemaekers JMM, Simons AHM, Carde P, Noordijk EM, Fermé C, Thomas J, Eghbali H, Kluin-Nelemans HC, Henry-Amar M. Gonadal Function in Males After Chemotherapy for Early-Stage Hodgkin's Lymphoma Treated in Four Subsequent Trials by the European Organisation for Research and Treatment of Cancer: EORTC Lymphoma Group and the Groupe d'Étude des Lymphomes de l'Adulte. J Clin Oncol 2007;25:2825-32. [PMID: 17515571 DOI: 10.1200/jco.2006.10.2020] [Citation(s) in RCA: 81] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
35
Klimm B, Eich HT, Haverkamp H, Lohri A, Koch P, Boissevain F, Trenn G, Worst P, Dühmke E, Müller RP, Müller-Hermelink K, Pfistner B, Diehl V, Engert A. Poorer outcome of elderly patients treated with extended-field radiotherapy compared with involved-field radiotherapy after chemotherapy for Hodgkin's lymphoma: an analysis from the German Hodgkin Study Group. Ann Oncol 2007;18:357-63. [PMID: 17071932 DOI: 10.1093/annonc/mdl379] [Citation(s) in RCA: 39] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]  Open
36
Tsang RW, Hodgson DC, Crump M. Hodgkin’s Lymphoma. Curr Probl Cancer 2006;30:107-58. [PMID: 16740424 DOI: 10.1016/j.currproblcancer.2006.04.001] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
37
Nogovà L, Diehl V, Engert A. Nodular lymphocyte-predominant Hodgkin's lymphoma. Curr Hematol Malig Rep 2006;1:60-5. [PMID: 20425333 DOI: 10.1007/s11899-006-0019-2] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
38
Nørgaard M, Larsson H, Pedersen G, Schønheyder HC, Sørensen HT. Risk of bacteraemia and mortality in patients with haematological malignancies. Clin Microbiol Infect 2006;12:217-23. [PMID: 16451407 DOI: 10.1111/j.1469-0691.2005.01298.x] [Citation(s) in RCA: 99] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
39
Moser EC, Noordijk EM, Carde P, Tirelli U, Baars JW, Thomas J, Bron D, Meerwaldt JH, van Glabbeke M, Raemaekers JMM, Kluin-Nelemans HC. Late non-neoplastic events in patients with aggressive non-Hodgkin's lymphoma in four randomized European Organisation for Research and Treatment of Cancer trials. ACTA ACUST UNITED AC 2006;6:122-30. [PMID: 16231850 DOI: 10.3816/clm.2005.n.038] [Citation(s) in RCA: 41] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
40
Nogová L, Rudiger T, Engert A. Biology, Clinical Course and Management of Nodular Lymphocyte-Predominant Hodgkin Lymphoma. Hematology 2006:266-72. [PMID: 17124071 DOI: 10.1182/asheducation-2006.1.266] [Citation(s) in RCA: 38] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
41
Klimm B, Engert A, Diehl V. Axillary swelling and a reduced general condition in a middle-aged man. ACTA ACUST UNITED AC 2005;1:51-4; quiz 1 p following 54. [PMID: 16264800 DOI: 10.1038/ncponc0024] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/24/2004] [Accepted: 09/17/2004] [Indexed: 11/09/2022]
42
Nogová L, Reineke T, Eich HT, Josting A, Müller-Hermelink HK, Wingbermühle K, Brillant C, Gossmann A, Oertel J, Bollen MV, Müller RP, Diehl V, Engert A. Extended field radiotherapy, combined modality treatment or involved field radiotherapy for patients with stage IA lymphocyte-predominant Hodgkin's lymphoma: a retrospective analysis from the German Hodgkin Study Group (GHSG). Ann Oncol 2005;16:1683-7. [PMID: 16093276 DOI: 10.1093/annonc/mdi323] [Citation(s) in RCA: 113] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]  Open
43
Klimm B, Diehl V, Pfistner B, Engert A. Current treatment strategies of the German Hodgkin Study Group (GHSG). Eur J Haematol 2005:125-34. [PMID: 16007881 DOI: 10.1111/j.1600-0609.2005.00466.x] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
44
Moser EC, Noordijk EM, van Glabbeke M, Teodorovic I, de Wolf-Peeters C, Carde P, Baars JW, Tirelli U, Raemaekers JMM, Kluin-Nelemans JC. Long-term efficacy of the CHVmP/BV regimen used for aggressive non-Hodgkin’s lymphoma in three randomised EORTC trials. Eur J Cancer 2004;40:474-80. [PMID: 14962711 DOI: 10.1016/j.ejca.2003.11.003] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/04/2003] [Revised: 09/30/2003] [Accepted: 11/04/2003] [Indexed: 10/26/2022]
45
Molin D. Bystander cells and prognosis in Hodgkin lymphoma. Review based on a doctoral thesis. Ups J Med Sci 2004;109:179-228. [PMID: 15508524 DOI: 10.3109/2000-1967-084] [Citation(s) in RCA: 18] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]  Open
46
Diehl V. Chemotherapy or combined modality treatment: the optimal treatment for Hodgkin's disease. J Clin Oncol 2003;22:15-8. [PMID: 14657229 DOI: 10.1200/jco.2004.10.910] [Citation(s) in RCA: 30] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
47
Hodgson DC, Tsang RW, Pintilie M, Sun A, Wells W, Crump M, Gospodarowicz MK. Impact of chest wall and lung invasion on outcome of stage I–II Hodgkin's lymphoma after combined modality therapy. Int J Radiat Oncol Biol Phys 2003;57:1374-81. [PMID: 14630276 DOI: 10.1016/s0360-3016(03)00765-x] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
48
Molin D, Enblad G, Gustavsson A, Ekman T, Erlanson M, Haapaniemi E, Glimelius B. Early and intermediate stage Hodgkin's lymphoma--report from the Swedish National Care Programme. Eur J Haematol 2003;70:172-80. [PMID: 12605661 DOI: 10.1034/j.1600-0609.2003.00030.x] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
PrevPage 1 of 1 1Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA